|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's range||200.97 - 206.25|
|52-week range||141.41 - 249.27|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||48.68|
|Forward dividend & yield||1.30 (0.65%)|
|Ex-dividend date||19 Jan 2022|
|1y target est||N/A|
Shares of Zoetis (NYSE: ZTS) had a strong 2021 as the animal health company posted solid growth throughout the year and consistently raised its guidance. Zoetis shares slumped through the first two months of the year as a solid fourth-quarter 2020 earnings report wasn't enough to give the stock a boost.
Banking on its strategic measures and a streamlined business, Mednax (MD) holds potential to reap benefits for investors.
Riding high on its strategic measures and a rising membership, Anthem (ANTM) holds prospects to reap benefits for investors.